SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-013262
Filing Date
2024-02-13
Accepted
2024-02-13 16:00:43
Documents
18
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193443-8k_pluriinc.htm   iXBRL 8-K 29634
2 SALES AGREEMENT, DATED FEBRUARY 13, 2024, BY AND BETWEEN THE COMPANY AND A.G.P. ea193443ex1-1_pluri.htm EX-1.1 252526
3 OPINION OF SULLIVAN & WORCESTER LLP ea193443ex5-1_pluri.htm EX-5.1 11158
7 GRAPHIC ex5-1_001.jpg GRAPHIC 10934
8 GRAPHIC ex5-1_002.jpg GRAPHIC 9173
  Complete submission text file 0001213900-24-013262.txt   562564

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE plur-20240213.xsd EX-101.SCH 3030
5 XBRL LABEL FILE plur-20240213_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE plur-20240213_pre.xml EX-101.PRE 22369
19 EXTRACTED XBRL INSTANCE DOCUMENT ea193443-8k_pluriinc_htm.xml XML 3610
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 24625504
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)